| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) | 
|---|
| 06/04/1992 | DE4038385A1 Sitosterol and its glycoside(s) with improved bio-availability - are in the form of microemulsions using lecithin as the carrier, isopropyl-myristate as the emulsifier and isopropanol as co-emulsifier  | 
| 06/04/1992 | DE4038203A1 Pharmaceutical spray-prepn. for admin. of nitrate(s) - esp. for treatment of cardiovascular, disorders, asthma, migraine and colic  | 
| 06/03/1992 | EP0488583A2 Improved kit and method for administration of bacillus calmette-guerin  | 
| 06/03/1992 | EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant  | 
| 06/03/1992 | EP0488181A1 Hard capsule preparation containing nifedipine  | 
| 06/03/1992 | EP0488142A1 Process for encapsulating solid or liquid lipophilic agents in phospholipid-liposomes and medicaments containing those liposomes  | 
| 06/03/1992 | EP0488139A1 Pharmaceutical composition comprising calcium polycarbophil  | 
| 06/03/1992 | EP0488137A2 Preparation for transdermal drug administration  | 
| 06/03/1992 | EP0488089A1 Diclofenac preparations for topical use  | 
| 06/03/1992 | EP0487973A1 Topical lotion containing Niclosamide  | 
| 06/03/1992 | EP0487774A1 A direct tabletting auxiliary  | 
| 06/03/1992 | EP0487768A1 Pharmaceutical composition with improved dissolution property  | 
| 06/03/1992 | EP0487729A1 Ketotifen preparation for external use  | 
| 06/03/1992 | EP0487632A1 Stabilized vaccine compositions  | 
| 06/03/1992 | EP0487615A1 Ferritin analogs.  | 
| 06/03/1992 | EP0487603A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it.  | 
| 06/03/1992 | EP0487575A1 Pharmaceutical formulations.  | 
| 06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions  | 
| 06/03/1992 | EP0359746B1 Use of vinyl alcohol homopolymers and copolymers for tableting active materials  | 
| 06/03/1992 | EP0219539B1 Transdermal nitroglycerin delivery system  | 
| 06/03/1992 | CN1061530A Medical health care cloth cushion for protecting chilblain  | 
| 06/03/1992 | CN1061527A Quickly effective atomized agent and sprayer for curing a cold and the preparation method thereof  | 
| 06/02/1992 | US5118808 Pharmaceutical preparations  | 
| 06/02/1992 | US5118779 Hydrophilic polyurethane elastomers  | 
| 06/02/1992 | US5118698 Pharmaceutical preparations  | 
| 06/02/1992 | US5118671 Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them  | 
| 06/02/1992 | US5118528 Precipitation of film-forming material and biologically active substance from solvent-non-solvent mixture  | 
| 06/02/1992 | US5118511 Emulsifier, protective colloid, drug dispersed in very small particles of edible oil or fat  | 
| 06/02/1992 | US5118510 Niacin drink mix formulation  | 
| 06/02/1992 | US5118509 Inducing skin tolerance to a sensitizing drug  | 
| 06/02/1992 | US5118508 Pharmaceutical composition  | 
| 06/02/1992 | US5118494 Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations  | 
| 06/02/1992 | CA1302279C Solid dispersion composition of fr-900506 substance  | 
| 06/02/1992 | CA1302278C Injection solutions of torasemide which are ready to use and processes for their preparation thereof  | 
| 06/02/1992 | CA1302272C Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and theiruse in treating clot formation  | 
| 06/02/1992 | CA1302269C Penetrating topical pharmaceutical compositions  | 
| 06/02/1992 | CA1302267C Oral therapeutic system having systemic action  | 
| 06/02/1992 | CA1302261C Buccal drug dosage form  | 
| 06/02/1992 | CA1302260C Drug delivery system and method of making the same  | 
| 06/02/1992 | CA1302259C Pharmaceutical formulations  | 
| 06/02/1992 | CA1302258C Pharmaceutical compositions comprising microcapsules  | 
| 06/02/1992 | CA1302257C Pharmaceutical formulation and a process for its preparation  | 
| 06/02/1992 | CA1302256C Topical drug release system  | 
| 06/02/1992 | CA1302255C Sustained release dosage form  | 
| 06/02/1992 | CA1302148C Method for preparing an effervescent granulate, an effervescent granulate made accordingly, and its utilization  | 
| 05/31/1992 | WO1992009263A1 Gel type compositions having improved oil control  | 
| 05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant  | 
| 05/30/1992 | CA2056032A1 Hard capsule preparation  | 
| 05/30/1992 | CA2031095A1 Process for producing liquid-loaded powders  | 
| 05/29/1992 | WO1992009252A1 Method and device for treating tobacco addiction  | 
| 05/29/1992 | WO1992008685A1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds  | 
| 05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent  | 
| 05/29/1992 | WO1992008477A1 Therapeutic agent for corneal lesion  | 
| 05/29/1992 | WO1992008467A1 Dispersion preparation  | 
| 05/29/1992 | WO1992008463A1 Direct compression method for preparing pills having cephalosporanic acid derivatives  | 
| 05/29/1992 | WO1992008459A1 Topical compositions for transdermal delivery of produg derivatives of morphine  | 
| 05/29/1992 | WO1992008447A1 Aerosol containing medicaments  | 
| 05/29/1992 | WO1992008446A1 Aerosol medicaments  | 
| 05/29/1992 | WO1992005866A3 Efficient microcapsule preparation and method of use  | 
| 05/29/1992 | CA2055715A1 Kit and method for administration of bacillus calmette-guerin  | 
| 05/28/1992 | WO1992009299A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same  | 
| 05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material  | 
| 05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material  | 
| 05/28/1992 | CA2072983A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same  | 
| 05/27/1992 | WO1992009635A1 Methyl pyrrolidinone chitosan, production process and uses thereof  | 
| 05/27/1992 | WO1992009283A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same  | 
| 05/27/1992 | WO1992009269A1 Oral spiramycine formulations and method for preparing same  | 
| 05/27/1992 | EP0487431A1 Laxative compositions and process for their preparation  | 
| 05/27/1992 | EP0487335A1 Pharmaceutical dosage forms of dihydropyridines  | 
| 05/27/1992 | EP0487066A1 Disinfectant composition  | 
| 05/27/1992 | EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent  | 
| 05/27/1992 | EP0486964A2 S(+)-Phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes  | 
| 05/27/1992 | EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it  | 
| 05/27/1992 | EP0486863A1 Antiacid compositions with prolonged gastric residence time  | 
| 05/27/1992 | EP0486854A1 Aqueous compositions containing calcitonin for the nasal administration  | 
| 05/27/1992 | EP0486563A1 Chewing gum composition with accelerated, controlled release of active agents.  | 
| 05/27/1992 | EP0486529A1 Transdermal nitroglycerin patch with penetration enhancers  | 
| 05/27/1992 | EP0486499A1 Stable ascorbic acid compositions.  | 
| 05/27/1992 | EP0201601B1 Glass microspheres  | 
| 05/27/1992 | DE4036332A1 Opthalmological contact gel - can be used in virectomy to hold contact lenses in place, in three mirror contact glass investigations and in echography  | 
| 05/27/1992 | CN2105281U Dental silver amalgam capsule  | 
| 05/27/1992 | CN1061405A Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids  | 
| 05/27/1992 | CN1061404A Complexes containing s(+) phenyl alkane acids and alpha-amino acids  | 
| 05/27/1992 | CA2096943A1 Oral spiramycine formulations and method for preparing same  | 
| 05/27/1992 | CA2074517A1 Methyl pyrrolidinone chitosan, production process and uses thereof  | 
| 05/27/1992 | CA2074484A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same  | 
| 05/26/1992 | US5117022 Antitumor  | 
| 05/26/1992 | US5116878 Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle  | 
| 05/26/1992 | US5116868 Glucose, antioxidant, ketone  | 
| 05/26/1992 | US5116847 Use of loperamide and related compounds for treatment of respiratory disease symptoms  | 
| 05/26/1992 | US5116839 Treatment of senility  | 
| 05/26/1992 | US5116819 Enteral diet for patients with pulmonary disease  | 
| 05/26/1992 | US5116817 LHRH preparations for intranasal administration  | 
| 05/26/1992 | US5116621 Anti-inflammatory analgesic patch  | 
| 05/26/1992 | US5116619 Vaginal progesterone tablet  | 
| 05/26/1992 | US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility  | 
| 05/26/1992 | US5116603 Oral antifungal preventative, and method of use  | 
| 05/26/1992 | US5116536 Preparation of pharmaceutical or cosmetic dispersions  | 
| 05/26/1992 | US5115805 Ultrasound-enhanced delivery of materials into and through the skin  | 
| 05/26/1992 | CA1301682C Microbial encapsulation  |